Isatin

Identification

Generic Name
Isatin
DrugBank Accession Number
DB02095
Background

Isatin is an indole derivative first obtained by Erdman and Laurent in 1841 as an oxidation product of Indigo dye with nitric acid and chromic acids. The compound is found in many plants and Schiff bases of Isatin are have been investigated for pharmaceutical applications.

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 147.1308
Monoisotopic: 147.032028409
Chemical Formula
C8H5NO2
Synonyms
  • 1H-indole-2,3-dione
External IDs
  • NSC-9262

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UAmine oxidase [flavin-containing] BNot AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as indolines. These are compounds containing an indole moiety, which consists of pyrrolidine ring fused to benzene to form 2,3-dihydroindole.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Indoles and derivatives
Sub Class
Indolines
Direct Parent
Indolines
Alternative Parents
Aryl ketones / Benzenoids / Vinylogous amides / Secondary carboxylic acid amides / Lactams / Azacyclic compounds / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives
Substituents
Aromatic heteropolycyclic compound / Aryl ketone / Azacycle / Benzenoid / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Dihydroindole / Hydrocarbon derivative / Ketone
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
indoledione (CHEBI:27539) / a small molecule (ISATIN)
Affected organisms
Not Available

Chemical Identifiers

UNII
82X95S7M06
CAS number
91-56-5
InChI Key
JXDYKVIHCLTXOP-UHFFFAOYSA-N
InChI
InChI=1S/C8H5NO2/c10-7-5-3-1-2-4-6(5)9-8(7)11/h1-4H,(H,9,10,11)
IUPAC Name
2,3-dihydro-1H-indole-2,3-dione
SMILES
O=C1NC2=CC=CC=C2C1=O

References

Synthesis Reference

Leandro Baiocchi, "Process for the synthesis of isatin derivatives." U.S. Patent US4256639, issued July, 1968.

US4256639
General References
Not Available
Human Metabolome Database
HMDB0061933
KEGG Compound
C11129
PubChem Compound
7054
PubChem Substance
46507369
ChemSpider
6787
BindingDB
11022
ChEBI
27539
ChEMBL
CHEMBL326294
ZINC
ZINC000002047514
PDBe Ligand
ISN
Wikipedia
Isatin
PDB Entries
1oja / 2bk5 / 2xfp / 5oji / 5ph6 / 5rtf / 6af5 / 6af9 / 6afa / 6afb
show 1 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)203 dec °CPhysProp
logP0.83HANSCH,C ET AL. (1995)
Predicted Properties
PropertyValueSource
Water Solubility2.77 mg/mLALOGPS
logP0.89ALOGPS
logP1.6Chemaxon
logS-1.7ALOGPS
pKa (Strongest Acidic)9.33Chemaxon
pKa (Strongest Basic)-5.6Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area46.17 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity40.48 m3·mol-1Chemaxon
Polarizability13.8 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+1.0
Blood Brain Barrier+0.9944
Caco-2 permeable+0.6443
P-glycoprotein substrateNon-substrate0.8274
P-glycoprotein inhibitor INon-inhibitor0.8426
P-glycoprotein inhibitor IINon-inhibitor0.8273
Renal organic cation transporterNon-inhibitor0.8946
CYP450 2C9 substrateNon-substrate0.8221
CYP450 2D6 substrateNon-substrate0.8111
CYP450 3A4 substrateNon-substrate0.5891
CYP450 1A2 substrateInhibitor0.8026
CYP450 2C9 inhibitorNon-inhibitor0.9332
CYP450 2D6 inhibitorNon-inhibitor0.8689
CYP450 2C19 inhibitorNon-inhibitor0.8833
CYP450 3A4 inhibitorNon-inhibitor0.9776
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7789
Ames testNon AMES toxic0.6182
CarcinogenicityNon-carcinogens0.9499
BiodegradationNot ready biodegradable0.6703
Rat acute toxicity2.0665 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9784
hERG inhibition (predictor II)Non-inhibitor0.9302
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-014j-3900000000-cfbe2c69370cb821719e
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0002-0900000000-b7740f917ea3a513cccf
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-014i-0900000000-7cc1e59d64b0f9fe75c7
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0006-9200000000-7222eca5f15462cb52d6
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0006-9000000000-9d8ae3e3d93ebbae650e
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0006-9000000000-5f853d2ccc4bbe2b3a89
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0002-0900000000-4d14e90a2ccd915ec028
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0002-1900000000-efd2670c6d91416ca123
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-001l-3900000000-a768411b3bdce1e8bbf7
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0f89-3900000000-00d17037a416b9858a30
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0fc0-7900000000-b2e65fbe547a142b1b3e
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-001j-0900000000-6129e468197154787423
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-01ot-6900000000-e172235ae1d7d5980b78
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0g5d-9600000000-3abf3b0049a56410c636
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-014l-9100000000-0fb3353ec5204cb4b15c
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0ik9-9000000000-82722063406d135a28ca
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-0900000000-181b0f53a5d55965e227
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-0900000000-e0194db7e73eaad09c8f
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-006t-0900000000-9e42c9b0ee88934c85ed
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-4900000000-c5fbcdf816eca750c2d3
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0v4i-9300000000-004f295468233cd161dd
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-1ddd4cf368fd6eff0f19
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-128.7965077
predicted
DarkChem Lite v0.1.0
[M-H]-128.8862077
predicted
DarkChem Lite v0.1.0
[M-H]-129.0910077
predicted
DarkChem Lite v0.1.0
[M-H]-121.965904
predicted
DeepCCS 1.0 (2019)
[M+H]+129.1266077
predicted
DarkChem Lite v0.1.0
[M+H]+129.4593077
predicted
DarkChem Lite v0.1.0
[M+H]+129.2215077
predicted
DarkChem Lite v0.1.0
[M+H]+125.29567
predicted
DeepCCS 1.0 (2019)
[M+Na]+129.1902077
predicted
DarkChem Lite v0.1.0
[M+Na]+129.2303077
predicted
DarkChem Lite v0.1.0
[M+Na]+129.1308077
predicted
DarkChem Lite v0.1.0
[M+Na]+134.18112
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Primary amine oxidase activity
Specific Function
Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral...
Gene Name
MAOB
Uniprot ID
P27338
Uniprot Name
Amine oxidase [flavin-containing] B
Molecular Weight
58762.475 Da

Enzymes

Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Inhibitor
General Function
Primary amine oxidase activity
Specific Function
Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral...
Gene Name
MAOB
Uniprot ID
P27338
Uniprot Name
Amine oxidase [flavin-containing] B
Molecular Weight
58762.475 Da
References
  1. Igosheva N, Lorz C, O'Conner E, Glover V, Mehmet H: Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells. Neurochem Int. 2005 Aug;47(3):216-24. doi: 10.1016/j.neuint.2005.02.011. [Article]
  2. Panova NG, Zemskova MA, Axenova LN, Medvedev AE: Does isatin interact with rat brain monoamine oxidases in vivo? Neurosci Lett. 1997 Sep 12;233(1):58-60. doi: 10.1016/s0304-3940(97)00597-1. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52